The anti-inflammatory effect of omega-3 fatty acids may lower the breast cancer risk of obese, post-menopausal women. A study published in Cancer Prevention Research suggests that omega-3 fatty acids have a specific protective effect for obese, post menopausal women with dense breast tissue. Andrea Manni, professor and division chief of endocrinology,Read
The addition of intravenous omega-3 fatty acids to anti-tumor medications for pancreatic cancer may improve quality of life (QOL) and clinical response, according to researchers from the University Hospitals of Leicester, UK. The authors report that the first clinical trial of intravenous (IV) ω-3FAs as a therapeutic agent in anyRead
By Kimberly Lord Stewart A new breed of dog, which is loyal and highly trainable with a keen sense of smell, may be the next tool for early cancer detection. The Russian airline Aeroflot and an R&D group have patented the Sulimov dog breed for airport security purposes but realizeRead
Frequent intake of aspirin may cut cervical cancer risk by half, according to a study led by researchers at Roswell Park Cancer Institute (RPCI). Frequent intake was defined by five or more years of use of 7 or more tablets per week. According to the American Cancer Society, 12,900 newRead
The use of dietary supplements among patients affected by cancer is extensive, with an estimated 20-90 % of patients using these products. Their use of these products is often not shared with the treating physician. “Doctors need to understand why patients with cancer use dietary supplements in the first place. Patients tend to use these supplements because they want to do everything possible to feel hopeful, empower themselves, enhance the body’s natural defenses, use less toxic treatments, or reduce side effects of mainstream treatments,” said Dr. Victor Sierpina, UTMB professor of family medicine. “In fact, most patients choose to use dietary supplements to improve their quality of life rather than seeking a cure for their disease.” In the September issue of Current Oncology Reports, researchers at University of Texas Medical Branch, Sierpina describes a patient centered approach to managing dietary supplement use in cancer care. By Moshe Frenkel and Victor Sierpina, published in Current Oncology, Sept. 2014.
For the first time ever, researchers have made a significant positive connection between biomarkers of oxidative sress, a standardized form of selenium-enriched yeast and reduced prostate cancer risk. Results from long-term clinical trial suggest that selenium-enriched yeast (SY), in a dose-dependent, standardized form from SelenoExcell, but not selenomethionine (SeMet) may be effective at reducing prostate cancer risk. This study confirmed reductions in biomarkers of oxidative stress following supplementation with the standardized form of SY but not SeMet in healthy men. By John P Richie Jr PhD, Karam el-Bayoumy PhD et al, published in Cancer Prevention Research, August 2014.
Nearly three-quarters of cancer patients who have major depression are not currently receiving treatment for depression, and that a new integrated treatment programme is strikingly more effective at reducing depression and improving quality of life than current care, according to three papers published in The Lancet Psychiatry, The Lancet, and The Lancet Oncology. Lead author Professor Michael Sharpe from the University of Oxford in the UK, says “The huge benefit that DCPC delivers for patients with cancer and depression shows what we can achieve for patients if we take as much care with the treatment of their depression as we do with the treatment of their cancer.” By M Sharpe, et al., published in the Lancet and Lancet Oncology, Aug. 2014.
It is widely accepted that physical inactivity leads to weight gain, cardiovascular disease and diabetes. New research links a sedentary lifestyle to certain cancers, specifically colon, lung and endometrial cancer, according to a study published June 16 in the JNCI: Journal of the National Cancer Institute. The research is significance as is shows sedentary behavior is emerging as an independent risk factor for cancer, chronic disease and mortality. However, in a clinical setting guidelines to improve activity levels for adult patients are poorly defined and difficult to implement.
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
